tuneTypical Dose
Typical protein-serving range depending on diet goals
Supplement
Soy Protein Isolate
Soy protein isolate
Evidence TierBWADA NOT PROHIBITED
watchEffect Window
Lipid effects accrue over weeks.
check_circleCompliance
WADA NOT PROHIBITED
Overview
Clinical Summary
Soy protein isolate modestly lowers LDL cholesterol and is a practical plant protein, but it is not a dramatic cardiometabolic intervention.
Soy protein isolate is one of the more evidence-backed plant proteins for lipids. The best human data support a modest LDL-lowering effect. That is useful, especially as part of a dietary pattern, but it is not large. Soy protein is also a practical complete plant protein. The common hormone fear around soy is generally more overstated than the lipid effect.
Soy protein may influence LDL cholesterol and related lipid metabolism while also functioning as a complete plant protein source.
Outcomes
What This Is Expected To Influence
Primary Outcomes
- Modest LDL-cholesterol reduction
Secondary Outcomes
- Complete plant-protein intake support
Safety
Contraindications and Interactions
Contraindications
- Soy allergy
Side effects
- GI intolerance
Interactions
No entries provided
Avoid if
- You have soy allergy
Evidence
Study-level References
soy-SRC-001Meta-analysis
Sourceopen_in_newJenkins DJA, et al. A Meta-Analysis of 46 Studies Identified by the FDA Demonstrates that Soy Protein Decreases Circulating LDL and Total Cholesterol Concentrations in Adults. J Nutr. 2019;149(6):968-981. doi:10.1093/jn/nxz041. PMID:31006811.
Population: Adults in soy-protein RCTs.
Dose protocol: Various soy-protein protocols across 46 studies
Key findings: Modest pooled LDL and total-cholesterol reduction.
Notes: Best lipid anchor.
Paper content
This is the best soy-protein lipid anchor. It supports a small but real LDL-lowering effect, which is more defensible than common hormone-fear narratives.
soy-SRC-002Systematic review and meta-analysis of randomized controlled trials.
Sourceopen_in_newAsbaghi O, Ashtary-Larky D, Mousa A, Rezaei Kelishadi M, Moosavian SP. The effects of soy products on cardiovascular risk factors in patients with type 2 diabetes: a systematic review and meta-analysis of clinical trials. Adv Nutr. 2022;13(2):455-473. doi:10.1093/advances/nmab121. PMID:34591084.
Population: Adults with type 2 diabetes from 22 randomized controlled trials.
Dose protocol: Soy product supplementation across 22 RCTs in T2D patients
Key findings: Reduced triglycerides by 24.73 mg/dL, total cholesterol by 9.84 mg/dL, LDL by 6.94 mg/dL, and CRP by 1.27 mg/L.
Notes: Extends lipid evidence into metabolically at-risk populations with consistent direction of effect.
Paper content
This systematic review and meta-analysis pooled 22 RCTs involving 867 patients with type 2 diabetes to evaluate the effects of soy products on cardiovascular risk factors. Soy significantly reduced triglycerides, total cholesterol, LDL cholesterol, and C-reactive protein. Subgroup analysis showed additional fasting glucose benefits in patients with elevated baseline glucose (above 126 mg/dL) and systolic blood pressure benefits in hypertensive participants. HDL cholesterol, fasting insulin, HbA1c, and HOMA-IR did not change significantly overall. The findings reinforce soy as a modest but meaningful cardiometabolic adjunct in metabolically at-risk populations.
soy-SRC-003Randomized controlled trial.
Sourceopen_in_newYao Y, Mak IEK, Sutanto CN, et al. Impact of quantity and source of dietary protein intake within a healthy dietary pattern on cardiovascular disease risk factors in Singapore older adults: a randomized controlled trial. Food Funct. 2025. doi:10.1039/d5fo03817k. PMID:41284351.
Population: 55 community-dwelling older adults in Singapore randomized to control, casein, or soy protein isolate arms.
Dose protocol: 20 g/day soy protein isolate versus casein versus control for 16 weeks
Key findings: Soy protein reduced total cholesterol by 0.28 mmol/L in older adults. Control group triglycerides worsened.
Notes: Adds direct head-to-head protein source comparison in older adults.
Paper content
This 16-week RCT compared 20 g/day soy protein isolate, 20 g/day casein protein, and a healthy dietary pattern control in 55 older adults. The soy protein arm showed a significant total cholesterol reduction of 0.28 mmol/L, while the control group saw a triglyceride increase that did not occur in either protein group. The results support soy protein as a practical dietary addition for maintaining favorable lipid profiles in older adults. The study adds direct comparative evidence between soy and casein protein within a real dietary context.